Back
Day Range
$1.67
$1.73
52-Week Range
$1.24
$3.34
Volume
12,000
50D / 200D Avg
$1.92
/
$2.04
Prev Close
$1.64
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -11.5 | 0.2 |
| P/B | 3.6 | 3.0 |
| ROE % | -27.7 | 3.6 |
| Net Margin % | -64.9 | 3.8 |
| Rev Growth 5Y % | 13.8 | 9.9 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$0.10
$0.09 – $0.12
|
695.90M | 1 |
| FY2029 |
$0.04
$0.03 – $0.05
|
534.02M | 1 |
| FY2028 |
-$0.02
-$0.02 – -$0.01
|
425.60M | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-02 | -$0.09 | -$0.10 | -9.2% |
| 2025-09-02 | -$0.10 | -$0.10 | +2.1% |
| 2025-03-04 | -$0.13 | -$0.10 | +20.3% |
| 2024-09-03 | -$0.10 | -$0.11 | -8.4% |
| 2024-06-10 | -$0.06 | -$0.13 | -103.0% |
| 2023-06-30 | -$0.09 | -$0.11 | -20.8% |
| 2022-12-31 | -$0.07 | -$0.09 | -25.0% |
| 2022-06-30 | -$0.10 | -$0.04 | +54.3% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 13.76% annually over 5 years — strong growth
Debt/Equity of 0.09 — conservative balance sheet
Negative free cash flow of -66.29M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8.44%
Capital efficient — spends only 1.56% of revenue on capex
Growth
Revenue Growth (5Y)
13.76%
Revenue (1Y)22.20%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-27.66%
ROIC-23.07%
Net Margin-64.85%
Op. Margin-69.36%
Safety
Debt / Equity
0.09
Current Ratio3.56
Interest Coverage-55.46
Valuation
P/E Ratio
-11.52
Forward P/EN/A
P/B Ratio3.61
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 22.20% | Revenue Growth (3Y) | 14.87% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 13.76% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 223.86M | Net Income (TTM) | -145.18M |
| ROE | -27.66% | ROA | -23.33% |
| Gross Margin | 58.64% | Operating Margin | -69.36% |
| Net Margin | -64.85% | Free Cash Flow (TTM) | -66.29M |
| ROIC | -23.07% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.09 | Current Ratio | 3.56 |
| Interest Coverage | -55.46 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -11.52 | Forward P/E | N/A |
| P/B Ratio | 3.61 | P/S Ratio | 7.47 |
| PEG Ratio | 1.35 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 6.12 | Fwd Earnings Yield | N/A |
| FCF Yield | -3.96% | ||
| Market Cap | 1.67B | Enterprise Value | 1.53B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 223.86M | 183.19M | 169.67M | 198.60M | 133.66M |
| Net Income | -145.18M | -146.19M | -154.51M | -91.03M | -167.61M |
| EPS (Diluted) | -0.15 | -0.16 | -0.19 | -0.11 | -0.20 |
| Gross Profit | 131.28M | 105.40M | 90.48M | 123.81M | 73.20M |
| Operating Income | -155.27M | -152.33M | -168.61M | -98.48M | -164.53M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 622.40M | 742.05M | 777.06M | 823.89M | 841.87M |
| Total Liabilities | 159.17M | 155.71M | 133.21M | 130.33M | 137.89M |
| Shareholders' Equity | 463.22M | 586.34M | 643.85M | 693.56M | 703.98M |
| Total Debt | 41.49M | 45.96M | 41.66M | 34.10M | 24.80M |
| Cash & Equivalents | 181.07M | 199.52M | 220.54M | 356.78M | 487.84M |
| Current Assets | 419.93M | 520.10M | 447.18M | 638.00M | 750.61M |
| Current Liabilities | 117.98M | 111.49M | 89.20M | 91.54M | 105.05M |